About

About Adgyl Lifesciences Adgyl Lifesciences is a leading contract research organization offering comprehensive safety assessment and translational research services to support Discovery, Preclinical, and Early Clinical development programs. With 30+ years of GLP experience, we ensure the highest standards of data integrity and reliability. Our AAALAC and OLAW accredited facility is SAM registered, and data from our studies have been successfully submitted to global regulatory authorities. We offer a strong platform for oncology and immuno oncology research. Our capabilities include xenograft and syngeneic tumour models, as well as humanized and orthotopic models. We also provide specialized systems for studying metastasis and angiogenesis. In house services such as histopathology, immunohistochemistry, biomarker analysis, and clinical biochemistry ensure seamless program execution. Our biologics capabilities cover CAR-T, CAR-NK, Cell & Gene Therapy, Antibodies, ADCs, and Peptides. The Biologics team supports discovery through functional and mechanistic assays, biodistribution, efficacy, and toxicology studies. We also conduct GLP regulatory studies, including immunogenicity and bioanalysis, for clinical programs and biosimilars. At Adgyl Lifesciences, we combine experience, scientific depth, and integrated capabilities to help advance your therapeutic programs. We look forward to meeting you at booth 2005. Email: enquiry@adgyllifesciences.com